Elevance Health price target raised to $439 from $358 at RBC Capital
RBC Capital analyst Ben Hendrix raised the firm's price target on Elevance Health to $439 from $358 and keeps a Sector Perform rating on the shares as part of a broader research note previewing Q2 earnings in Healthcare Services and Managed Care. The firm is expecting payor strength seen since April to sustain amid gro